Molecular events in germ cell tumours: Linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin

James Korkola, Jane Houldsworth, George J. Bosl, R. S K Chaganti

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Germ cell tumours (GCTs) represent the leading cause of cancer-related morbidity and mortality in young men aged 18-35 years. Transformation of the cell of origin results in tumours with several unique properties. GCTs are characterized by gain of the short arm of chromosome 12 in almost all cases, a frequency of genomic alteration not seen in any other solid tumours. GCTs are truly pluripotent, giving rise to cells of somatic and extra-embryonic lineages, which results in tumours with a spectrum of differentiation that rivals that seen in normal embryogenesis and development. Despite the presence of genomic instability and many oncogenic changes, GCTs are highly curable, even in the metastatic setting, due to their extreme sensitivity to cisplatin-based chemotherapy. In this review we highlight some of the molecular events associated with the genesis, differentiation and chemotherapeutic response of these tumours, and discuss how these alterations are linked with biological features unique to germ cells.

Original languageEnglish (US)
Pages (from-to)1334-1338
Number of pages5
JournalBJU International
Volume104
Issue number9 B
DOIs
StatePublished - Nov 2009
Externally publishedYes

Fingerprint

Chromosomes, Human, Pair 12
Germ Cell and Embryonal Neoplasms
Cisplatin
Neoplasms
Genomic Instability
Germ Cells
Embryonic Development
Morbidity
Drug Therapy
Mortality

ASJC Scopus subject areas

  • Urology

Cite this

Molecular events in germ cell tumours : Linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin. / Korkola, James; Houldsworth, Jane; Bosl, George J.; Chaganti, R. S K.

In: BJU International, Vol. 104, No. 9 B, 11.2009, p. 1334-1338.

Research output: Contribution to journalArticle

Korkola, James ; Houldsworth, Jane ; Bosl, George J. ; Chaganti, R. S K. / Molecular events in germ cell tumours : Linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin. In: BJU International. 2009 ; Vol. 104, No. 9 B. pp. 1334-1338.
@article{a07dc67e4c0644c18db9abef62564321,
title = "Molecular events in germ cell tumours: Linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin",
abstract = "Germ cell tumours (GCTs) represent the leading cause of cancer-related morbidity and mortality in young men aged 18-35 years. Transformation of the cell of origin results in tumours with several unique properties. GCTs are characterized by gain of the short arm of chromosome 12 in almost all cases, a frequency of genomic alteration not seen in any other solid tumours. GCTs are truly pluripotent, giving rise to cells of somatic and extra-embryonic lineages, which results in tumours with a spectrum of differentiation that rivals that seen in normal embryogenesis and development. Despite the presence of genomic instability and many oncogenic changes, GCTs are highly curable, even in the metastatic setting, due to their extreme sensitivity to cisplatin-based chemotherapy. In this review we highlight some of the molecular events associated with the genesis, differentiation and chemotherapeutic response of these tumours, and discuss how these alterations are linked with biological features unique to germ cells.",
author = "James Korkola and Jane Houldsworth and Bosl, {George J.} and Chaganti, {R. S K}",
year = "2009",
month = "11",
doi = "10.1111/j.1464-410X.2009.08855.x",
language = "English (US)",
volume = "104",
pages = "1334--1338",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "9 B",

}

TY - JOUR

T1 - Molecular events in germ cell tumours

T2 - Linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin

AU - Korkola, James

AU - Houldsworth, Jane

AU - Bosl, George J.

AU - Chaganti, R. S K

PY - 2009/11

Y1 - 2009/11

N2 - Germ cell tumours (GCTs) represent the leading cause of cancer-related morbidity and mortality in young men aged 18-35 years. Transformation of the cell of origin results in tumours with several unique properties. GCTs are characterized by gain of the short arm of chromosome 12 in almost all cases, a frequency of genomic alteration not seen in any other solid tumours. GCTs are truly pluripotent, giving rise to cells of somatic and extra-embryonic lineages, which results in tumours with a spectrum of differentiation that rivals that seen in normal embryogenesis and development. Despite the presence of genomic instability and many oncogenic changes, GCTs are highly curable, even in the metastatic setting, due to their extreme sensitivity to cisplatin-based chemotherapy. In this review we highlight some of the molecular events associated with the genesis, differentiation and chemotherapeutic response of these tumours, and discuss how these alterations are linked with biological features unique to germ cells.

AB - Germ cell tumours (GCTs) represent the leading cause of cancer-related morbidity and mortality in young men aged 18-35 years. Transformation of the cell of origin results in tumours with several unique properties. GCTs are characterized by gain of the short arm of chromosome 12 in almost all cases, a frequency of genomic alteration not seen in any other solid tumours. GCTs are truly pluripotent, giving rise to cells of somatic and extra-embryonic lineages, which results in tumours with a spectrum of differentiation that rivals that seen in normal embryogenesis and development. Despite the presence of genomic instability and many oncogenic changes, GCTs are highly curable, even in the metastatic setting, due to their extreme sensitivity to cisplatin-based chemotherapy. In this review we highlight some of the molecular events associated with the genesis, differentiation and chemotherapeutic response of these tumours, and discuss how these alterations are linked with biological features unique to germ cells.

UR - http://www.scopus.com/inward/record.url?scp=70350459186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350459186&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2009.08855.x

DO - 10.1111/j.1464-410X.2009.08855.x

M3 - Article

C2 - 19840009

AN - SCOPUS:70350459186

VL - 104

SP - 1334

EP - 1338

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 9 B

ER -